Doceree Appoints Matthew Baggett as SVP of AI Solutions to Propel reptwin.ai Forward

Doceree Elevates AI with Matthew Baggett's Appointment



Doceree, recognized as the world's first AI-powered Operating System tailored for healthcare marketing, has made a significant leadership change by appointing Matthew Baggett as Senior Vice President of AI Solutions. This strategic move is set to boost the development and commercialization of reptwin.ai, the company's innovative solution designed to integrate media intelligence with real-world healthcare data and physician engagement metrics.

In a landscape where life sciences organizations are increasingly pressured to demonstrate accountable and impactful engagement strategies, Baggett’s extensive experience is expected to play a pivotal role. His previous position as Senior Vice President of Pharma Sales at Level Ex (now called Relevate Health Games) provided him with a solid foundation in spearheading physician-focused digital engagement strategies. His leadership at Skipta, a prominent platform for healthcare professionals, where he handled data scaling, further amplifies his credentials.

Harshit Jain, MD, the CEO and founder of Doceree, expressed his enthusiasm about Baggett joining the team, stating, "Our ongoing commitment to advancing AI innovation is crucial to our growth strategy. The capabilities of reptwin.ai present a novel approach to engaging physicians—focusing on unifying context, data, and physician behaviors. Matthew’s rich background in physician engagement will undeniably sharpen our future growth trajectory."

Moreover, Co-founder and President Kamya Elawadhi highlighted Baggett's unique blend of skills that intersect the realms of data, technology, and commercial achievements. She conveyed confidence that Baggett’s industry insights would refine how Doceree connects AI innovations with meaningful outcomes for life sciences brands.

In his own words, Baggett remarked on the fragmented nature of healthcare marketing and the value reptwin.ai brings in remedying these challenges. By merging AI, media intelligence, and behavioral data into a singular platform, it offers healthcare brands a structured way to engage physicians that is both compliant and measurable, tracking interactions from the initial touchpoint to final engagement.

This ambitious pursuit of integrated solutions showcases Doceree's commitment not just to innovation, but also to ensuring that healthcare marketing is as precise and impactful as possible. Thomas Shea, the Chief Revenue Officer for Patient Affordability and AI at Doceree, noted the importance of Baggett’s appointment in moving reptwin.ai closer to its market goals.

Baggett’s new role aligns with Doceree’s overarching objectives to expand its leadership team while advancing its AI-powered healthcare marketing ecosystem. This includes innovations in point-of-care and programmatic advertising combined with affordability insights and conversational AI tools. He will be working under the direct supervision of Thomas Shea, ensuring strategy alignment and execution within this dynamic environment.

About Doceree


Doceree has emerged as a pioneering force in AI-powered, hyper-personalized healthcare messaging in just five years. Their focus is on delivering better interactions through context-driven healthcare professional engagement while adhering to privacy compliance. The company is committed to reshaping how healthcare professionals interact, ultimately seeking to achieve measurable outcomes that benefit both practitioners and the patients they serve. To learn more, visit Doceree’s Website.

As Baggett steps into this influential role, the focus will be on driving significant advancements within healthcare marketing, reflecting a trend towards greater accountability and effectiveness grounded in innovative technology.

Topics Consumer Technology)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.